DKC1 and prostate carcinoma: The overexpression of dyskerin has been reported previously in several cancers, including neuroblastoma [12], lymphoma [13], melanoma [14], breast cancer [15], [16], prostate cancer [17], colorectal cancer [18], [19], and ovarian carcinoma [20].